Evofem Inc Drug Patent Portfolio

Evofem Inc owns 2 orange book drugs protected by 15 US patents Given below is the list of Evofem Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11684607 Secnidazole for use in the treatment of bacterial vaginosis 16 Sep, 2035
Active
US10335390 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
Active
US10682338 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
Active
US10849884 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
Active
US10857133 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
Active
US11000507 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
Active
US11000508 Secnidazole for use in the treatment of trichomoniasis 04 Sep, 2035
Active
US11020377 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
Active
US11324721 Secnidazole for use in the treatment of trichomoniasis 04 Sep, 2035
Active
US11602522 Secnidazole for use in the treatment of sexually transmitted infection 04 Sep, 2035
Active
US10568855 Compositions and methods for enhancing the efficacy of contraceptive microbicides 15 Mar, 2033
Active
US11337989 Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound 15 Mar, 2033
Active
US11439610 Compositions and methods for enhancing the efficacy of contraceptive microbicides 15 Mar, 2033
Active
US11992472 Compositions and methods for enhancing the efficacy of contraceptive microbicides 15 Mar, 2033
Active
US6706276 Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa 06 Mar, 2024 Expired


Given below is the list of recent legal activities going on the following drug patents of Evofem Inc.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 17 Jul, 2024 US11000508
Payment of Maintenance Fee, 4th Year, Large Entity 17 Jul, 2024 US11000507
Interim Patent Term Extension Granted 30 Jan, 2024 US6706276
Payment of Maintenance Fee, 4th Year, Large Entity 11 Dec, 2023 US10857133
Payment of Maintenance Fee, 4th Year, Large Entity 11 Dec, 2023 US10849884
Change in Power of Attorney (May Include Associate POA) 08 Sep, 2023 US11337989
Email Notification 08 Sep, 2023 US11337989
Payment of Maintenance Fee, 4th Yr, Small Entity 09 Aug, 2023 US10568855
Interim Patent Term Extension Granted 04 Aug, 2023 US6706276
Payment of Maintenance Fee, 4th Year, Large Entity 28 Jun, 2023 US10682338
Email Notification 27 Jun, 2023 US11684607
Electronic Review 27 Jun, 2023 US11684607
Patent eGrant Notification 27 Jun, 2023 US11684607
Mail Patent eGrant Notification 27 Jun, 2023 US11684607
Patent Issue Date Used in PTA Calculation 27 Jun, 2023 US11684607


Evofem Inc's Family Patents

Evofem Inc drugs have patent protection in a total of 23 countries. It's US patent count contributes only to 32.3% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Evofem Inc Drug List

Given below is the complete list of Evofem Inc's drugs and the patents protecting them.


1. Phexxi

Phexxi is protected by 5 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10568855 Compositions and methods for enhancing the efficacy of contraceptive microbicides 15 Mar, 2033
(8 years from now)
Active
US11337989 Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound 15 Mar, 2033
(8 years from now)
Active
US11439610 Compositions and methods for enhancing the efficacy of contraceptive microbicides 15 Mar, 2033
(8 years from now)
Active
US11992472 Compositions and methods for enhancing the efficacy of contraceptive microbicides 15 Mar, 2033
(8 years from now)
Active
US6706276 Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa 06 Mar, 2024
(7 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Phexxi's drug page


2. Solosec

Solosec is protected by 10 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11684607 Secnidazole for use in the treatment of bacterial vaginosis 16 Sep, 2035
(10 years from now)
Active
US10335390 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
(10 years from now)
Active
US10682338 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
(10 years from now)
Active
US10849884 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
(10 years from now)
Active
US10857133 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
(10 years from now)
Active
US11000507 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
(10 years from now)
Active
US11000508 Secnidazole for use in the treatment of trichomoniasis 04 Sep, 2035
(10 years from now)
Active
US11020377 Secnidazole for use in the treatment of bacterial vaginosis 04 Sep, 2035
(10 years from now)
Active
US11324721 Secnidazole for use in the treatment of trichomoniasis 04 Sep, 2035
(10 years from now)
Active
US11602522 Secnidazole for use in the treatment of sexually transmitted infection 04 Sep, 2035
(10 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Solosec's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List